Michael Burkard
Impact in
- Genetics top 10%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
-
- Chemical Synthesis and Analysis
- Melanoma and MAPK Pathways
Papers in
-
- Chemical Synthesis and Analysis 3
- Enzyme function and inhibition 2
- Genetics 6
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 6
- Co-authors
- John S. Zuzack (7 shared papers)Torsten Stein (2 shared papers)Lajos Gera (4 shared papers)John M. Stewart (4 shared papers)Eric T. Whalley (5 shared papers)Karl‐Dieter Entian (1 shared paper)Val S. Goodfellow (3 shared papers)Mary C.M. Weiser‐Evans (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (2 papers)Journal of Microbiological Methods (2 papers)Molecular Cancer Therapeutics (1 paper)Molecular Diversity (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Michael Burkard
17 papers receiving 245 citations
Peers
Comparison fields: 5 of 61
- Genetics 88
- Molecular Biology 164
- Oncology 58
- Organic Chemistry 59
- Toxicology 7
Countries citing papers authored by Michael Burkard
This map shows the geographic impact of Michael Burkard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Burkard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Burkard more than expected).
Fields of papers citing papers by Michael Burkard
This network shows the impact of papers produced by Michael Burkard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Burkard. The network helps show where Michael Burkard may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Burkard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 33 | |
| 2 | 2019 | 29 | |
| 3 | 1996 | 28 | |
| 4 | 1996 | 26 | |
| 5 | 1996 | 25 | |
| 6 | 1996 | 24 | |
| 7 | 2007 | 21 | |
| 8 | 2000 | 19 | |
| 9 | 2008 | 16 | |
| 10 | 1996 | 16 | |
| 11 | 2014 | 9 | |
| 12 | 1996 | 5 | |
| 13 | 2015 | 5 | |
| 14 | 1997 | 4 | |
| 15 | 1994 | 3 | |
| 16 | 2020 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 1989 | 1 | |
| 19 | 2008 | 0 |
About Michael Burkard
Michael Burkard is a scholar working on Molecular Biology, Genetics, Oncology, Hematology and Organic Chemistry, having authored 19 papers that have together received 268 indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Peptidase Inhibition and Analysis (3 papers), Chemical Synthesis and Analysis (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Bacteriophages and microbial interactions (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Enzyme function and inhibition (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Genetics (88 citations), Molecular Biology (164 citations), Oncology (58 citations), Organic Chemistry (59 citations) and Toxicology (7 citations). Michael Burkard has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include John S. Zuzack, Torsten Stein, Lajos Gera, John M. Stewart, Eric T. Whalley, Karl‐Dieter Entian, Val S. Goodfellow, Mary C.M. Weiser‐Evans, Kurt R. Stenmark and Christopher P. Laudeman. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Microbiological Methods, Molecular Cancer Therapeutics and Molecular Diversity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.